Eugene Oltz, PhD
College of Medicine
Molecular Biology and Cancer Genetics
Dr. Oltz studies the genetic, epigenetic, and topological mechanisms that govern gene expression programs in normal and transformed lymphocytes. Insights from these studies are being leveraged to create targeted epigenetic therapeutics for cancer and autoimmunity. In addition, the regulatory modules we uncovered in natural killer cells can be engineered to alter their phenotypes, with a goal of enhancing their utility as adoptive cell therapeutics for cancer. His laboratory also has an active research program to investigate the impact of DNA damage on chromatin-based regulation of gene expression.
460 W 12th Ave, Columbus, Oh 43210